Literature DB >> 27613543

Molecular cytogenetic characterization of two established ESFT cell lines.

Masako Ishiguro1, Mutsumi Yuki2, Tomoko Fukushige2, Mikio Mizoguchi2, Yasuhiko Kaneko3, Takeshita Morishige2, Hiroshi Iwasaki4.   

Abstract

Ewing's sarcoma/primitive neuroectodermal tumor/Askin's tumor (Ewing`s sarcoma family of tumors: ESFT) is the most common type of malignant tumor of bone and soft tissue in children and young adults, and morphologically is a member of a group of small round cell tumors. We report, here, on the establishment of two human ESFT cell lines, FU-PNET-3 and FU-PNET-4, from the iliac and the chest wall, respectively, the cells of both cell lines were tumorigenic in immunodeficient mice. Histologically, both original and xenograft tumors and cultured cells were composed of small round cells with positive immunoreactivity for CD99 and Nkx2.2. Molecular biological examination demonstrated chimeric transcripts of EWSR1 exon 7 to FLI1 exon 6 in FU-PNET-3 cells, and EWSR1 exon 10 to FLI1 exon 6 in FU-PNET-4 cells. Cytogenetic analysis revealed chromosome translocation t(11;22)(q24;q12) and some secondary changes in both cultured cells. These histological, molecular biological, and cytogenetical findings indicate ESFT in both cell lines. ESFT is well studied, but its recurrent fusion genes are heterogeneous and its biological behaviors are unclear. The FU-PNET-3 and FU-PNET-4 cell lines have been well examined and may become useful tools for studying the genetic and biological behavioral properties of ESFT.

Entities:  

Keywords:  Cell line; ESFT; EWSR1; FLI1

Mesh:

Year:  2016        PMID: 27613543     DOI: 10.1007/s13577-016-0145-7

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.174


  29 in total

1.  Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.

Authors:  Sonja Chen; Kemal Deniz; Yun-Shao Sung; Lei Zhang; Sarah Dry; Cristina R Antonescu
Journal:  Genes Chromosomes Cancer       Date:  2015-12-22       Impact factor: 5.006

2.  Molecular diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor in formalin-fixed paraffin-embedded tissues by RT-PCR and fluorescence in situ hybridization.

Authors:  Xiang Qian; Long Jin; Brandon M Shearer; Rhett P Ketterling; Syed M Jalal; Ricardo V Lloyd
Journal:  Diagn Mol Pathol       Date:  2005-03

3.  Ewing's sarcoma of bone: the detection of specific transcripts in a large, consecutive series of formalin-fixed, decalcified, paraffin-embedded tissue samples using the reverse transcriptase-polymerase chain reaction.

Authors:  D C Mangham; A Williams; D J McMullan; J McClure; V P Sumathi; R J Grimer; A M Davies
Journal:  Histopathology       Date:  2006-03       Impact factor: 5.087

4.  A new member of the ETS family fused to EWS in Ewing tumors.

Authors:  M Peter; J Couturier; H Pacquement; J Michon; G Thomas; H Magdelenat; O Delattre
Journal:  Oncogene       Date:  1997-03-13       Impact factor: 9.867

5.  NKX2.2 is a useful immunohistochemical marker for Ewing sarcoma.

Authors:  Akihiko Yoshida; Shigeki Sekine; Koji Tsuta; Masashi Fukayama; Koh Furuta; Hitoshi Tsuda
Journal:  Am J Surg Pathol       Date:  2012-07       Impact factor: 6.394

6.  Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases.

Authors:  Andrew L Folpe; John R Goldblum; Brian P Rubin; Bahig M Shehata; Wendy Liu; Angelo P Dei Tos; Sharon W Weiss
Journal:  Am J Surg Pathol       Date:  2005-08       Impact factor: 6.394

7.  Visceral primitive peripheral neuroectodermal tumors: a clinicopathologic and molecular study.

Authors:  M J O'Sullivan; E J Perlman; J Furman; P A Humphrey; L P Dehner; J D Pfeifer
Journal:  Hum Pathol       Date:  2001-10       Impact factor: 3.466

8.  A variant Ewing's sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1.

Authors:  I S Jeon; J N Davis; B S Braun; J E Sublett; M F Roussel; C T Denny; D N Shapiro
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

9.  Fusion of an ETS-family gene, EIAF, to EWS by t(17;22)(q12;q12) chromosome translocation in an undifferentiated sarcoma of infancy.

Authors:  Y Kaneko; K Yoshida; M Handa; Y Toyoda; H Nishihira; Y Tanaka; Y Sasaki; S Ishida; F Higashino; K Fujinaga
Journal:  Genes Chromosomes Cancer       Date:  1996-02       Impact factor: 5.006

10.  Establishment and characterization of a new Ewing's sarcoma cell line.

Authors:  K Kodama; O Doi; M Higashiyama; Y Mori; T Horai; R Tateishi; Y Aoki; S Misawa
Journal:  Cancer Genet Cytogenet       Date:  1991-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.